Semaglutide FLOW Kidney and Heart Findings: What Patients Should Know 6th June 20266th June 2026 by Living Diabetes Editorial A new FLOW analysis reports that semaglutide kidney and all-cause death benefits were consistent across cardiovascular-risk groups in adults with type 2 diabetes and chronic kidney disease.
Blood Pressure Targets for Kidney Health With Diabetes 4th June 20261st April 2026 by Living Diabetes Editorial Team Blood pressure targets in diabetes and kidney disease are individualized. Learn what affects the goal and what to track.
SGLT2 Inhibitors for Kidney Protection: Benefits and Risks 3rd June 202630th March 2026 by Living Diabetes Editorial Team SGLT2 inhibitors can protect kidneys in selected people with diabetes or CKD. Learn benefits, risks, and safety questions.
